StonvexLoading…
StonvexStonvexStonvexCore line items from SRTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $197.14M | $146.82M | $225.18M | $146.12M |
Operating Income | $-22.35M | $-22.52M | $-68.12M | $-53.53M |
Net Income | $41.35M | $-27.31M | $-56.08M | $-27.26M |
EPS (Diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 |
Total Assets | $325.47M | $256.68M | $294.94M | $325.02M |
Total Liabilities | $46.40M | $34.74M | $60.64M | $50.54M |
Cash & Equivalents | $30.97M | $18.38M | $27.87M | $41.34M |
Free Cash Flow OCF − CapEx | $-58.51M | $-33.38M | $-34.46M | $-37.86M |
Shares Outstanding | 82.09M | 77.50M | 73.52M | 71.24M |